242 related articles for article (PubMed ID: 19212024)
1. Successful reintroduction of previously failed ACE inhibitor therapy following stenting of atherosclerotic renovascular disease.
Balachandran KP; Oldroyd KG
Indian Heart J; 2008; 60(1):55-7. PubMed ID: 19212024
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme inhibition in renal disease; contrasting effects on renal function in renal artery stenosis and progressive renal injury.
Jackson B; Johnston CI
J Hum Hypertens; 1989 Jun; 3 Suppl 1():107-15. PubMed ID: 2674436
[TBL] [Abstract][Full Text] [Related]
3. [Predictors of successful renal artery revascularization in atherosclerotic renovascular disease].
Flisiński M; Manitius J
Pol Merkur Lekarski; 2005 Aug; 19(110):206-10. PubMed ID: 16245436
[TBL] [Abstract][Full Text] [Related]
4. Stenting for atherosclerotic renal artery stenosis.
Carr TM; Sabri SS; Turba UC; Park AW; Saad WE; Angle JF; Matsumoto AH
Tech Vasc Interv Radiol; 2010 Jun; 13(2):134-45. PubMed ID: 20540922
[TBL] [Abstract][Full Text] [Related]
5. [Palliative percutaneous transluminal renal angioplasty and stenting in elderly patients for serious coronary heart disease with renal arterial stenosis].
Geng QS; Zhou YL; Huang WH; Luo JF; Zhao HL; Chen JY
Di Yi Jun Yi Da Xue Xue Bao; 2005 Jul; 25(7):912-3. PubMed ID: 16027098
[TBL] [Abstract][Full Text] [Related]
6. Renal function and effectiveness of angiotensin-converting enzyme inhibitor therapy in patients with chronic stable coronary disease in the Prevention of Events with ACE inhibition (PEACE) trial.
Solomon SD; Rice MM; A Jablonski K; Jose P; Domanski M; Sabatine M; Gersh BJ; Rouleau J; Pfeffer MA; Braunwald E;
Circulation; 2006 Jul; 114(1):26-31. PubMed ID: 16801465
[TBL] [Abstract][Full Text] [Related]
7. Update on the management of atherosclerotic renal artery disease.
Fenstad ER; Kane GC
Minerva Cardioangiol; 2009 Feb; 57(1):95-101. PubMed ID: 19202521
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of atherosclerotic renal artery stenosis. Low dosage ACE inhibitors and angiotensin-receptor blockers are justified in certain cases].
Alhadad A; Sterner G; Herlitz H
Lakartidningen; 2009 Oct 28-Nov 3; 106(44):2836-8, 2840. PubMed ID: 19967962
[No Abstract] [Full Text] [Related]
9. Renal failure and concurrent RAAS blockade in older CKD patients with renal artery stenosis: an extended Mayo Clinic prospective 63-month experience.
Onuigbo MA; Onuigbo NT
Ren Fail; 2008; 30(4):363-71. PubMed ID: 18569908
[TBL] [Abstract][Full Text] [Related]
10. The cardioprotective effects of the angiotensin-converting enzyme inhibitor perindopril in patients with stable coronary artery disease are not modified by mild to moderate renal insufficiency: insights from the EUROPA trial.
Brugts JJ; Boersma E; Chonchol M; Deckers JW; Bertrand M; Remme WJ; Ferrari R; Fox K; Simoons ML;
J Am Coll Cardiol; 2007 Nov; 50(22):2148-55. PubMed ID: 18036453
[TBL] [Abstract][Full Text] [Related]
11. [Atherosclerotic renal artery stenosis].
Rammer M; Kramar R; Eber B
Dtsch Med Wochenschr; 2007 Nov; 132(46):2458-62. PubMed ID: 17987555
[TBL] [Abstract][Full Text] [Related]
12. [Revascularization of total renal artery occlusion by angioplasty and stent placement].
Fernandez-Fresnedo G; Piña T; Mateos Chaparro F; Sanz de Castro S; González-Tutor A; Bustamante M; de Francisco AL; Arias M
Nefrologia; 2005; 25(4):434-7. PubMed ID: 16231512
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin converting enzyme inhibition and renal insufficiency in patients with bilateral renovascular disease.
Dominiczak A; Isles C; Gillen G; Brown JJ
J Hum Hypertens; 1988 Jun; 2(1):53-6. PubMed ID: 3070034
[TBL] [Abstract][Full Text] [Related]
14. In-stent restenosis of the renal artery in a single kidney patient: the role of ACEI in the therapeutic choice.
Cianci R; Gigante A; Polidori L; Di Donato D; Martina P; Barbano B; Renzulli R; Zaccaria A; Fuiano G
Angiology; 2009; 60(4):496-503. PubMed ID: 18796449
[TBL] [Abstract][Full Text] [Related]
15. Stenting of renal artery stenosis in coronary artery disease (RAS-CAD) study: a prospective, randomized trial.
Marcantoni C; Zanoli L; Rastelli S; Tripepi G; Matalone M; Di Landro D; Scandura S; Tamburino C; Zoccali C; Castellino P
J Nephrol; 2009; 22(1):13-6. PubMed ID: 19229814
[TBL] [Abstract][Full Text] [Related]
16. Predictive factors and therapeutic approach of renovascular disease: four years' follow-up.
Ziakka S; Ursu M; Poulikakos D; Papadopoulos C; Karakasis F; Kaperonis N; Papagalanis N
Ren Fail; 2008; 30(10):965-70. PubMed ID: 19016147
[TBL] [Abstract][Full Text] [Related]
17. Clinical benefit of renal artery angioplasty with stenting for the control of recurrent and refractory congestive heart failure.
Gray BH; Olin JW; Childs MB; Sullivan TM; Bacharach JM
Vasc Med; 2002; 7(4):275-9. PubMed ID: 12710843
[TBL] [Abstract][Full Text] [Related]
18. Should angiotensin-converting enzyme-inhibitors be used to improve outcome in patients with coronary artery disease and 'preserved' left ventricular function?
Fox K; Ferrari R; Yusuf S; Borer JS
Eur Heart J; 2006 Sep; 27(18):2154-7. PubMed ID: 16905555
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-converting enzyme inhibition in patients with coronary artery disease and preserved left ventricular function Ischemia Management with Accupril post-bypass graft via inhibition of angiotensin-converting enzyme (IMAGINE) compared with the other major trials in coronary artery disease.
van Gilst WH; Warnica JW; Baillot R; Johnstone D; Calciu CD; Block P; Myers MG; Chocron S; Rouleau JL;
Am Heart J; 2006 Jun; 151(6):1240-6. PubMed ID: 16781228
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous revascularization of persistent renal artery in-stent restenosis.
Patel PM; Eisenberg J; Islam MA; Maree AO; Rosenfield KA
Vasc Med; 2009 Aug; 14(3):259-64. PubMed ID: 19651676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
